spacer
home > epc > summer 2002 > offering a global service to support clinical trial
PUBLICATIONS
European Pharmaceutical Contractor

Offering a Global Service to Support Clinical Trial

Speed, quality and continuity of service are essential when it comes to the analysis of samples taken in clinical trials. Pharmaceutical and biotechnology companies require sample turnaround within 24 hours because patients may require further testing or treatment based on laboratory results. In addition to analytical quality, logistics are critical to ensuring rapid shipment and results turnaround, and therefore the location of laboratories is fundamental.

For a Phase I/IIa study involving a limited number of sites, logistics tend not to be as complex as for a multi-site Phase IIb/III study, which are often conducted on a number of continents. Each country will have its own custom regulations and it is essential that a central laboratory understands them and knows the best ways to prevent shipment delays. For a successful Phase IIb/III trial, the location of laboratories is fundamental. For example, it is almost impossible to undertake a study in South Africa which requires rapid sample analysis if the central laboratory is located in Europe or North America.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Daniel Chapple, Business Development Director and Paul Travis, Head of Central Laboratory Services at CentraLabS

Dr Daniel Chapple is Business Development Director of CentraLabS and is responsible for the company's business throughout Europe, Russia, Asia and South Africa.

With a PhD in Biochemistry and Microbiology, Daniel previously lectured in drug discovery and has acted as a Consultant to a number of development companies.

spacer
Dr Daniel Chapple
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI expert forecasts ‘huge growth in Middle East manufacturing with Europe a medium-term target’

CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region. Government incentive schemes to increase domestic production, coupled with a brand friendly environment and rising healthcare needs is fuelling surging demand – with many new companies and plants launching in the last two years alone.
More info >>

White Papers

Exploring Protein Stability by nanoDSF

NanoTemper Technologies GmbH

nanoDSF determines thermal and chemical protein stability with ultra-high resolution and with unmatched reproducibility. The detection of the intrinsic tryptophan and tyrosin fluorescence enables measurements at close-to-native conditions in any buffer, even in the presence of detergents. nanoDSF is applied in antibody engineering, membrane protein research, formulation and quality control.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement